onc212
Anti-pancreatic cancer activity of ONC212 involves the unfolded protein response (UPR) and is reduced by IGF1-R and GRP78/BIP
Oncotarget 2017 PMID: 29137221
Chimerix is now part of Jazz Pharmaceuticals. Learn more at www.jazzpharma.com
onc212